The Imperative for KAM in Pharma
PM360
OCTOBER 28, 2022
Two of ZS’ major studies suggest that the trend towards more advanced KAM strategies and capabilities will continue to accelerate for pharma manufacturers. Furthermore, these studies demonstrate how KAM must be treated not simply as a role or as a sales or market access initiative, but as an organization-wide business strategy.
117 
Let's personalize your content